American Shared Hospital Services Reports 15.9% Revenue Growth but Faces Financial Challenges

American Shared Hospital Services (ASHS) reported a revenue increase of 15.9% for the first quarter of 2026, totaling $7.08 million compared to $6.11 million in the same period of 2025. The growth was driven primarily by a significant rise in direct patient services revenue, which surged to $4.06 million from $3.12 million year-over-year. The leasing segment also saw a modest increase, with revenues rising to $3.02 million from $2.99 million, attributed to a higher volume of Gamma Knife and Proton Beam Radiation Therapy (PBRT) procedures.

Despite the revenue growth, ASHS reported a net loss of $612,000 for the quarter, a slight improvement from the $625,000 loss recorded in the prior year. The company’s operating loss decreased to $924,000 from $1.30 million, reflecting improved operational efficiency. The increase in costs of revenue, which rose to $5.80 million from $5.17 million, was primarily due to higher maintenance and operating costs associated with the company's facilities, particularly in Rhode Island and Puebla, Mexico.

Operationally, ASHS has expanded its service offerings, with the number of PBRT fractions increasing to 1,003 from 831, and Gamma Knife procedures rising to 229 from 208. The company’s international facilities in Peru and Ecuador reported a 44% and 49% increase in procedure volumes, respectively, following equipment upgrades. However, the company faced challenges with a decrease in Gamma Knife procedures from its leasing segment due to the expiration of a customer contract.

ASHS is currently navigating financial challenges, including non-compliance with certain covenants under its credit agreements, which could jeopardize its liquidity and ability to continue as a going concern. The company is in discussions with Fifth Third Bank regarding potential amendments to extend the maturity date of its $22 million credit agreement, which matured on April 9, 2026. As of March 31, 2026, ASHS had cash and cash equivalents of $5.22 million, a decrease from $11.49 million a year earlier, raising concerns about its ability to meet upcoming financial obligations.

Looking ahead, ASHS plans to continue its focus on expanding its direct patient services segment and enhancing operational efficiencies. The company is also committed to securing financing for its capital commitments, which include the purchase and installation of new Gamma Knife and LINAC systems. However, the ongoing discussions with lenders and the need to address its financial covenant defaults will be critical to its future operations and growth strategy.